Pharmaceutical Meeting Guidelines
Since 1999 our Managing Director has been involved with multiple pharmaceutical companies in the consolidation and implementation of pharmaceutical guidelines. We are knowledgeable on Federal Drug Administration guidelines and procedures. In addition, we are well versed in the latest PhRMA guidelines for a pharmaceutical company’s interaction with healthcare professionals both domestic and international. We understand that each of our clients interpret these guidelines to best suit their business needs, and we plan events accordingly, always keeping the professional objectives of the meeting at the forefront. This is PPI’s leading consultation value to our pharmaceutical partners.
PPI currently supports detailed Healthcare Compliance Reporting with several of our clients. We are able to report detailed spending by category for each Healthcare Professional that attends the meeting.
PPI has a working knowledge of the following pharmaceutical practices. PPI advises the typical norms and works with each client to achieve their individual compliance goals.
- PhRMA (Pharmaceutical Research and Manufacturers of America)
- EFPIA (European Federation of Pharmaceutical Industries and Associations)
- EphMRA (European Pharmaceutical Market Research Association)
- AdvaMed (Advanced Medical Technology Association) as well as country specific regulations such as the German FSA Code of Conduct and the Spanish FARMAINDUSTRIA Code of Practice Surveillance.
- ABPI (Association of British Pharmaceutical Industry)
- IFPMA (International Federation of Pharmaceutical Manufacturers and Associations)
- PMCPA Guidelines (Prescription Medicines Code of Practice Authority)
- PhRMA Code, EMEA Meeting Code and Canadian Rx&D Code.
- Sunshine Act Reporting